Weekly Round Up

Research Deep DiveLong Form ArticleWeekly Round Up
Weekly Round UpWeekly Round Up
FemTech to $130B, a $2B MedTech Move, and a 65% Drop in Late-Stage VC

FemTech to $130B, a $2B MedTech Move, and a 65% Drop in Late-Stage VC

FemTech targets a $130B valuation and Teleflex executes $2B in strategic carve-outs, while late-stage HealthTech funding drops 65% amid a widening global confidence gap.

Weekly Round UpWeekly Round Up
$850B WellTech Boom, $1B Exit, and the New Rules Reshaping U.S. Healthcare

$850B WellTech Boom, $1B Exit, and the New Rules Reshaping U.S. Healthcare

UnitedHealth finalizes its Latin America retreat with a $1B sale to Patria as WellTech surges to an $850B opportunity, while 46 states race to regulate the growing AI adoption gap.

Weekly Round UpWeekly Round Up
The Rise of RPM and AI in Europe: Signals for Healthcare Operators and Investors

The Rise of RPM and AI in Europe: Signals for Healthcare Operators and Investors

RPM adoption is accelerating and AI is reshaping European healthtech, signaling a new investment cycle driven by data, automation, and smarter care delivery.

Weekly Round UpWeekly Round Up
Inside: Nutraceutical Surge, GCC’s Digital Pivot, Home Care Winners

Inside: Nutraceutical Surge, GCC’s Digital Pivot, Home Care Winners

The $1T nutraceuticals market takes center stage as GCC bets big on AI and genomics. Plus, a dive into monitoring PE, the Kenvue deal, and North American home health.

Weekly Round UpWeekly Round Up
Inside Europe’s €440B Pharma Powerhouse: Who’s Winning Big?

Inside Europe’s €440B Pharma Powerhouse: Who’s Winning Big?

Europe’s drug engine still dominates on scale and exports — but lags in innovation speed, regulation, and access. The world’s watching how it adapts.

Weekly Round UpWeekly Round Up
AI Gets Its MD: Why More Docs Are Prescribing Algorithms (and What It Means for You)

AI Gets Its MD: Why More Docs Are Prescribing Algorithms (and What It Means for You)

AI is no longer a healthcare experiment — it’s a daily diagnostic tool. As physicians trade paperwork for algorithms, efficiency is rising, but so are the ethical and operational stakes.

Weekly Round UpWeekly Round Up
Who's Winning The $86.7B Obesity Therepeutics Boom

Who's Winning The $86.7B Obesity Therepeutics Boom

The $86.7B obesity drug boom is redefining healthcare, as pharma giants and investors race to turn a global health crisis into the next trillion-dollar opportunity.

Weekly Round UpWeekly Round Up
The $8.55T Shift Reshaping Healthcare — And What Comes Next

The $8.55T Shift Reshaping Healthcare — And What Comes Next

Value-based care, private equity, and GenAI are redrawing healthcare’s financial map. The next phase isn’t about growth alone—it’s about redefining where and how value is created.

Weekly Round UpWeekly Round Up
The $37B Boom: Can Gamification Really Heal Healthcare?

The $37B Boom: Can Gamification Really Heal Healthcare?

Gamification is transforming patient engagement and digital care—but can it truly heal what healthcare can’t?

Weekly Round UpWeekly Round Up
Wellness Booms, AI Crawls, and Europe Leaves the U.S. Behind

Wellness Booms, AI Crawls, and Europe Leaves the U.S. Behind

Global wellness spending just passed $5 trillion, fueled by products, tech, and lifestyle real estate. The market’s flexing fast—and only investors who adapt to this convergence will keep up.

Weekly Round UpWeekly Round Up
Healthcare Cybersecurity Is Booming — Don’t Get Left Behind

Healthcare Cybersecurity Is Booming — Don’t Get Left Behind

The healthcare cybersecurity market is set to nearly quadruple to $126B by 2034. Investors, providers, and tech players who move now will define the next decade of digital trust.

Weekly Round UpWeekly Round Up
Pharma’s $3 Trillion Path and Pfizer’s $7.3B Obesity Push

Pharma’s $3 Trillion Path and Pfizer’s $7.3B Obesity Push

Global pharma races toward $3 trillion as Asia accelerates growth, while Pfizer doubles down on obesity drugs with a $7.3B bet.